» Articles » PMID: 8509457

A Role for TGF-beta in Oligodendrocyte Differentiation

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1993 Jun 1
PMID 8509457
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Oligodendrocyte-type-2 astrocyte (O-2A) glial progenitor cells undergo a limited number of mitotic divisions in response to PDGF before differentiating into oligodendrocytes, the myelin-forming cell of the CNS. We examined the mechanism limiting O-2A proliferation, and demonstrate that these cells secrete an inhibitor of cell proliferation that can be neutralized with antibodies to TGF-beta. O-2A cells also secrete an inhibitory activity that cannot be neutralized with TGF-beta antibodies. O-2A progenitor cultures express TGF-beta 1 isoform and its transcript, while oligodendrocyte cultures express TGF-beta 1, beta-2, and beta-3 isoforms. Both recombinant TGF-beta 1 and O-2A conditioned medium inhibit the proliferation of O-2A progenitor cells cultured in the presence of PDGF, and this inhibition can be partially neutralized with polyclonal TGF-beta antibodies. Thus, TGF-beta produced by O-2A cells may limit PDGF-driven mitosis and promote oligodendrocyte development. TGF-beta is a less potent inhibitor of O-2A proliferation when these cells are cultured in the presence of bFGF, suggesting that bFGF interferes with TGF-beta signaling. Thus, the production of TGF-beta by cells in the O-2A lineage may account for the distinct effects of PDGF and bFGF on O-2A progenitor cell proliferation. Moreover, our results suggest that TGF-beta may be an important mediator of oligodendrocyte differentiation.

Citing Articles

A New Acquaintance of Oligodendrocyte Precursor Cells in the Central Nervous System.

Ma Z, Zhang W, Wang C, Su Y, Yi C, Niu J Neurosci Bull. 2024; 40(10):1573-1589.

PMID: 39042298 PMC: 11422404. DOI: 10.1007/s12264-024-01261-8.


Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics.

Prapas P, Anagnostouli M Int J Mol Sci. 2024; 25(13).

PMID: 39000461 PMC: 11242320. DOI: 10.3390/ijms25137354.


Early Postnatal Expression of Tgfβ-1 and Fgf-2 Correlates With Regenerative Functions of Unrestricted Somatic Stem Cell Infusion After Rabbit GMH-IVH.

Finkel D, Malfa A, Liao Y, Purohit D, Hu F, Sulaymankhil D Stem Cells Transl Med. 2023; 12(12):811-824.

PMID: 37774396 PMC: 10726409. DOI: 10.1093/stcltm/szad064.


Roles and regulation of microglia activity in multiple sclerosis: insights from animal models.

Distefano-Gagne F, Bitarafan S, Lacroix S, Gosselin D Nat Rev Neurosci. 2023; 24(7):397-415.

PMID: 37268822 DOI: 10.1038/s41583-023-00709-6.


Transforming growth factor β (TGF-β) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches.

Esmaeilzadeh A, Mohammadi V, Elahi R Mol Biol Rep. 2023; 50(7):6121-6131.

PMID: 37204543 DOI: 10.1007/s11033-023-08419-z.


References
1.
Frater-Schroder M, Muller G, Birchmeier W, Bohlen P . Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun. 1986; 137(1):295-302. DOI: 10.1016/0006-291x(86)91209-x. View

2.
Heimark R, Twardzik D, Schwartz S . Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science. 1986; 233(4768):1078-80. DOI: 10.1126/science.3461562. View

3.
Baird A, Durkin T . Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun. 1986; 138(1):476-82. DOI: 10.1016/0006-291x(86)90305-0. View

4.
Louis J, Muir D, Varon S . Autocrine inhibition of mitotic activity in cultured oligodendrocyte-type-2 astrocyte (O-2A) precursor cells. Glia. 1992; 6(1):30-8. DOI: 10.1002/glia.440060105. View

5.
Pringle N, Mudhar H, Collarini E, Richardson W . PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development. 1992; 115(2):535-51. DOI: 10.1242/dev.115.2.535. View